Company intelligence / Profile preview

Shanghai TTM-Bio Technology

Shanghai, China

Ownership: Private
Development stage: Other

Overview

Company produces and sells high-purity natural plant monomers, herbal intermediates, and HSCCC instruments; has industrialized production of Huperzine A with 20 kg annual capacity.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

GE Healthcare Bio-sciences Co., Ltd.Institute of Process Engineering, Chinese Academy of SciencesNational Engineering Research Center for Traditional Chinese MedicineShanghai Jiao Tong University

Beyond the preview

Go deeper on Shanghai TTM-Bio Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai TTM-Bio Technology.

Explore the full profile